In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Itamar Medical Ltd.

www.itamar-medical.com

Latest From Itamar Medical Ltd.

Deals Shaping The Medical Industry, July/August 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced May and June 2014.

BioPharmaceutical Medical Device

Sleep Apnea Devices: The Changing Of The Guard

The current specialty-dominated care paradigm for sleep apnea can't scale-up to meet the demands of an enormous and serious chronic disease. New companies help move diagnosis and treatment to the physicians that see patients first.
Medical Device Strategy

Once Sluggish Sleep Apnea Gets Active

The past year was a busy one in the sleep apnea sector of the respiratory market. All three major segments of the sleep apnea market--sleep testing equipment, continuous positive airway pressure (CPAP) devices, and therapeutic implants--were represented by the year's deals, which include four acquisitions and two venture financings, and we're not even counting the $4.9 billion acquisition of Respironics by Philips, which was announced at the tail end of 2007.

Sleep Apnea: A High Growth Device Market Awakens

There's a reason why Philips paid $5 billion and a premium to buy Respironics. Sleep apnea is an enormous emerging opportunity: in the US, 38 million patients have the disease, and there are compelling clinical reasons to treat them. That's big business for device companies, if only they can access patients and establish new referral patterns in a highly fragmented market.
Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Cardiovascular
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Itamar Medical Ltd.
  • Senior Management
  • Gilad Glick, PhD, Pres. & CEO
    Shaul Sharoni, SVP & CFO
    Eldad Singer, VP, Res. & European Sales
    Efrat Litman, VP, R&D
    Christopher F Hallett, VP, Sales, North America
  • Contact Info
  • Itamar Medical Ltd.
    Phone: (972) 4-6177000
    9 Halamish St.
    P.O. Box 3579 Caesarea, Haifa District, 3088900
    Israel
Advertisement
Advertisement
UsernamePublicRestriction

Register